Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients

Cancer Letters

Volumn 130, Issue 1-2, 1998, Pages 69-76

  Obermair, Andreas ^a   Speiser, Paul ^a   Reisenberger, Klaus ^a   Ullrich, Robert ^b   Czerwenka, Klaus ^b   Kaider, Alexandra ^b   Zeillinger, Robert ^a   Miksche, Michael ^c  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Borschkegasse 8A A 1090   (Austria)

Author keywords

Basic fibroblast growth factor; Ovarian cancer; Prognosis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ETOPOSIDE; IFOSFAMIDE; PLATINUM DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CYTOPLASM; CYTOSOL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROBABILITY; TIME;

ADULT; AGED; FEMALE; FIBROBLAST GROWTH FACTOR 2; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS;

FALLOPIA;

EID: 0032516645     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00119-0     Document Type: Article

References (34)

1. Klagsbrun M. The fibroblast growth factor family: structural and biological properties. Prog. Growth Factor Res. 1:1989;207-235.
2. Burgess W.H., Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58:1989;575-606.
3. Gospodarowicz D., Neufeld G., Schweigerer L. Fibroblast growth factor. Mol. Cell. Endocrinol. 46:1986;187-204.
4. Sliutz G., Tempfer C., Obermair A., Reinthaller A., Gitsch G., Kainz C. Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer Lett. 94:1995;227-231.
5. Nguyen M., Watanabe H., Budson A.E., Richie J.P., Hayes D.F., Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst. 86:1994;356-361.
6. Li V.W., Folkerth R.D., Watanabe H., Rupnick M., Barnes P., Scott R.M., Black P.M., Sallan S.E., Folkman J. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet. 344:1994;82-86.
7. Blood C.H., Zetter B.R. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta. 1032:1990;89-118.
8. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol. Int. 19:1995;431-444.
9. Berchuck A., Olt G.J., Everitt L., Soisson A.P., Bast R.C. Jr., Boyer C.M. The role of peptide growth factors in epithelial ovarian cancer. Obstet. Gynecol. 75:1990;255-262.
10. Crickard K., Gross J.L., Crickard U., Yoonessi M., Lele S., Herblin W.F., Eidsvoog K. Basic fibroblast growth factor and receptor expression in human ovarian cancer. Gynecol. Oncol. 55:1994;277-284.
11. Di Blasio A.M., Cremonesi L., Vigano P., Ferrari M., Gospodarowicz D., Vignali M., Jaffe R.B. Basic fibroblast growth factor and its receptor messenger ribonucleic acids are expressed in human ovarian epithelial neoplasms. Am. J. Obstet. Gynecol. 169:1993;1517-1523.
12. Speirs V., Jenkins S., White M.C. Growth factor regulation of 17 beta-hydroxysteroid dehydrogenase activity in a human ovarian cell line: modulation by 17 beta-estradiol. Anticancer Res. 13:1993;1399-1403.
13. Potgens A.J., Westphal H.R., de Waal R.M., Ruiter D.J. The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis. Biol. Chem. Hoppe Seyler. 376:1995;57-70.
14. Zagzag D. Angiogenic growth factors in neural embryogenesis and neoplasia. Am. J. Pathol. 146:1995;293-309.
15. Chen J.K., Shen L.S., Chao H.H. Correlation of transformation from epithelial to mesenchymal-like morphology and endogenous bFGF levels in human nasopharyngeal carcinoma cells. J. Cell. Physiol. 160:1994;401-408.
16. Reed J.A., McNutt N.S., Albino A.P. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression. Am. J. Pathol. 144:1994;329-336.
17. Soutter A.D., Nguyen M., Watanabe H., Folkman J. Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. Cancer Res. 53:1993;5297-5299.
18. Czubayko F., Smith R.V., Chung H.C., Wellstein A. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J. Biol. Chem. 269:1994;28243-28248.
19. D'Amore P.A. Modes of FGF release in vivo and in vitro. Cancer Metastasis Rev. 9:1990;227-238.
20. Reynolds K., Farzaneh F., Collins W.P., Campbell S., Bourne T.H., Lawton F., Moghaddam A., Harris A.L., Bicknell R. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J. Natl. Cancer Inst. 86:1994;1234-1238.
21. S.F. Serov, R.E. Scully, L.H. Sorbin, Histological typing of ovarian tumors, International Histological Classification of Tumors, No. 9, WHO, Geneva, 1973, p. 17.
22. Day T.G., Gallager H.S., Rutledge F.N. Epithelial carcinoma of the ovary: the prognostic importance of histologic grade. Natl. Cancer Inst. Monogr. 42:1975;15-21.
23. Matsuzaki K., Yoshitake Y., Matuo Y., Sasaki H., Nishikawa K. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc. Natl. Acad. Sci. USA. 86:1989;9911-9915.
24. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1985;457-481.
25. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50:1966;163-170.
26. Cox D.R. Regression models and life tables. J. R. Stat. Soc. B. 34:1972;187-220.
27. Fujimoto K., Ichimori Y., Kakizoe T., Okajima E., Sakmoto H., Sugimura T., Terada M. Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem. Biophys. Res. Commun. 180:1991;386-392.
28. Allen L.E., Maher P.A. Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line. J. Cell. Physiol. 155:1993;368-375.
29. Ueba T., Nosaka T., Takahashi J.A., Shibata F., Florkiewicz R.Z., Vogelstein B., Oda Y., Kikuchi H., Hatanaka M. Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells. Proc. Natl. Acad. Sci. USA. 91:1994;9009-9013.
30. Anandappa S.Y., Winstanley J.H., Leinster S., Green B., Rudland P.S., Barraclough R. Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br. J. Cancer. 69:1994;772-776.
31. Hasegawa Y., Takada M., Yamamoto M., Saitoh Y. The gradient of basic fibroblast growth factor concentration in human pancreatic cancer cell invasion. Biochem. Biophys. Res. Commun. 200:1994;1435-1439.
32. Yamanaka Y., Friess H., Buchler M., Beger H.G., Uchida E., Onda M., Kobrin M.S., Korc M. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res. 53:1993;5289-5296.
33. Nanus D.M., Schmitz-Dräger B.J., Motzer R.J., Lee A.C., Vlamis V., Cordon Cardo C., Albino A.P., Reuter V.E. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J. Natl. Cancer Inst. 85:1993;1597-1599.
34. Emoto N., Isozaki O., Ohmura E., Ito F., Tsushima T., Shizume K., Demura H., Toma H. Basic fibroblast growth factor (FGF-2) in renal cell carcinoma, which is indistinguishable from that in normal kidney, is involved in renal cell carcinoma growth. J. Urol. 152:1994;1626-1631.